FDA
approval
· 2022-04-29
FDA Approved: BALZIVA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for BALZIVA (norethindrone and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BALZIVA (NORETHINDRONE AND ETHINYL ESTRADIOL)